[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
October 26, 1984


JAMA. 1984;252(16):2245-2246. doi:10.1001/jama.1984.03350160113033

Senile macular degeneration is rapidly becoming the most frequent cause of blindness of the aged population in the Western world. One of the most significant publications of the past 18 months is the report from the collaborative study of the National Eye Institute1 concerned with the photocoagulation treatment of this disease.

The study showed that eyes with evidence of a symptomatic choroidal neovascularization will benefit from light-coagulation treatment. Photocoagulation, therefore, is indicated only for a small minority of patients with senile macular degeneration, but it is a most important subgroup because symptomatic choroidal neovascularization is the most frequent cause for severe visual loss in this disease.

A similar study2 was undertaken on the macular changes in the so-called histoplasmosis syndrome, which occurs mainly in persons in the Midwestern states. The results were as convincing as those found for the senile macular degeneration study.

It can therefore be said

Macular Photocoagulation Study Group:  Argon laser photocoagulation for senile macular degeneration: Results of a randomized clinical trial .  Arch Ophthalmol 1982;100:912-918.Crossref
Macular Photocoagulation Study Group:  Argon laser photocoagulation for ocular histoplasmosis: Results of a randomized clinical trial .  Arch Ophthalmol 1983;101:1347-1357.Crossref
Shea M:  Early vitrectomy in proliferative diabetic retinopathy .  Arch Ophthalmol 1983;101:1204-1205.Crossref
Goldberg MF:  Neodymium-YAG lasers for 'noninvasive' intraocular surgery , in Ernest JT (ed):  The Year Book of Ophthalmology . Chicago, Year Book Medical Publishers Inc, 1984, pp 323-333.
Patz A:  Current therapy of retrolental fibroplasia: Retrolental fibroplasia .  Ophthalmology 1983;90:425-427.